Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.82ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.70ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.70ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.43ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.43ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.559ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.559ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.406ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.406ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.69ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.69ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.47ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.47ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.18ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAY.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.55ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.55ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BY.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BY.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EA.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EA.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BC.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BC.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
P.1.17.1 (Gamma)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.1.17.1 (Gamma)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.41ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.41ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.375ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.375ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.8.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.8.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBSENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBSENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.2.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.2.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAHENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAHENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBJ.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBJ.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.62ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.62ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.82ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used